TAE Life Sciences’ Neutron Beam System Receives Acceptance, Allowing BNCT Clinical Trials to Begin in China

A Key Component of Neuboron’s NeuPex AB-BNCT System, TAE Life Sciences’ Neutron Beam System Receives Performance Acceptance and Passes Class III Registration Inspection IRVINE, Calif., April 3, 2024 /PRNewswire/ — TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks